封面
市场调查报告书
商品编码
1612108

酒精使用障碍市场:按治疗类型、障碍类型、分销管道划分 - 全球预测 2025-2030

Alcohol Use Disorder Market by Treatment Type (Behavioral Therapy, Detoxification, Inpatient Rehabilitation), Disorder Type (Alcohol Abuse, Alcohol Dependence, High-Functioning Alcoholism), Distribution Channel - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年酒精使用障碍市场价值为12.1亿美元,预计到2024年将达到12.8亿美元,复合年增长率为6.50%,到2030年将达到18.8亿美元。

酒精使用障碍 (AUD) 包括各种导致痛苦和伤害的问题饮酒行为,其一般特征是儘管会产生负面后果,但仍无法控製酒精摄取量。解决澳元问题的必要性源于其对公共卫生的重大影响,包括社会、经济和健康相关的负担。其范围涵盖旨在预防和治疗、康復计划、公共卫生倡议和政策制定的医疗干预措施。最终用途范围主要包括医疗保健提供者、復健中心、製药公司和政府机构。市场成长要素包括心理健康意识的提高、治疗方法技术的进步以及政府促进公共卫生的措施。新药和数位健康平台的快速发展为市场拓展提供了机会。在建议方面,公司可以利用个人化医疗和数位治疗工具的不断增长趋势来提高用户参与度和治疗效果。

主要市场统计
基准年[2023] 12.1亿美元
预计年份 [2024] 12.8亿美元
预测年份 [2030] 18.8亿美元
复合年增长率(%) 6.50%

然而,该市场面临局限性,例如与澳元相关的耻辱、高昂的治疗成本以及阻碍市场渗透的严格法律规范。此外,发展中地区的文化差异和意识缺乏也是成长的挑战。技术创新的重点发展领域包括开发更有效、更少成瘾的药物、人工智慧主导的早期检测和个人化治疗计划解决方案以及整合远端医疗和常规治疗的综合支援系统等。这一市场趋势揭示了结合药理和行为干预的整体方法的趋势。市场的本质是动态的,受到社会对心理健康态度不断变化和快速发展的技术格局的推动。透过专注于综合护理模式和利用资料分析,公司不仅可以改善治疗结果,还可以透过有效解决酒精使用障碍来扩大其市场份额并确保强劲成长。

市场动态:针对快速发展的酒精使用障碍市场揭示的关键市场洞察

供需的动态交互作用正在改变酒精使用障碍市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球药物滥用案例不断增加
    • 政府预防、诊断和治疗酒精成瘾的措施和计划
    • 传播预防和管理饮酒的数位和远端医疗策略
  • 市场限制因素
    • 性能限制和效率评估的复杂性
  • 市场机会
    • 提高酒精使用障碍治疗和诊断有效性和效率的研究措施和进展
    • 继续核准有助于管理酒精使用的设备、药物和配方
  • 市场挑战
    • 制定酒精使用疾患治疗和诊断策略的复杂性

波特的五力:驾驭酒精使用障碍市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解酒精使用疾患市场的外在影响

外在宏观环境因素在塑造酒精使用疾患市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解酒精使用障碍市场的竞争格局

对酒精使用障碍市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 酒精使用疾患市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估酒精使用障碍市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了酒精使用障碍市场的成功之路

对于旨在加强在全球市场的影响力的公司来说,酒精使用障碍市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,以帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地吸毒案件呈现上升趋势
      • 政府预防、诊断和治疗酒精滥用障碍的措施和计划
      • 传播预防和管理酒精消费的数位和远端医疗策略
    • 抑制因素
      • 性能限制和评估效率的复杂性
    • 机会
      • 提高治疗和诊断有效性和效率的研究倡议和进展
      • 帮助管理酒精摄取的设备、药物和配方正在核准中
    • 任务
      • 制定治疗和诊断策略的复杂性
  • 市场区隔分析
    • 治疗类型:增加对行为疗法的兴趣,以有效控製酒精使用障碍
    • 分销管道:增加零售药局非处方药的使用以支持康復
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章酒精使用疾患市场治疗类型

  • 行为疗法
  • 排毒
  • 住院復健
  • 药物治疗

第 7 章 按市场混乱类型分類的酒精使用障碍

  • 酗酒
  • 酒精成瘾
  • 高功能酒精成瘾

第八章酒精使用疾患市场:依通路

  • 医院药房
  • 零售药局/药局

第九章美洲酒精使用疾患市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太酒精使用疾患市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的酒精使用疾患市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • 研究人员获得 340 万美元津贴,用于研究残障人士的酒精使用障碍
    • Affect 筹集了 1600 万美元的与成瘾相关的资金筹措
    • Indivior 完成对 Opiant Pharmaceuticals, Inc. 的收购
  • 战略分析和建议

公司名单

  • Addex Therapeutics
  • Adial Pharmaceuticals
  • Alkermes
  • Astellas Pharma
  • Beckley Psytech Limited
  • BioCorRx, Inc.
  • Bioprojet
  • Clairvoyant Therapeutics
  • Corcept Therapeutics Inc.
  • GlaxoSmithKline PLC
  • Indivior Inc.
  • Kinnov Therapeutics
  • Kinoxis Therapeutics
  • Lundbeck
  • MediciNova
  • Merck & Co. Inc.
  • Omeros Corporation
  • Otsuka Pharmaceuticals
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-351BAD503A27

The Alcohol Use Disorder Market was valued at USD 1.21 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 6.50%, to USD 1.88 billion by 2030.

Alcohol Use Disorder (AUD) encompasses a range of problematic drinking behaviors leading to distress or harm, and it is commonly characterized by an inability to control alcohol intake despite adverse consequences. The necessity for addressing AUD arises from its significant public health impact, which includes social, economic, and health-related burdens. Its application spans medical interventions, rehabilitation programs, public health initiatives, and policy-making aimed at prevention and treatment. The end-use scope primarily involves healthcare providers, rehabilitation centers, pharmaceutical companies, and government agencies. Market growth factors include increasing awareness of mental health, technological advancements in treatment methods, and government initiatives promoting public health. The surge in the development of novel pharmaceuticals and digital health platforms presents opportunities for market expansion. In terms of recommendations, businesses can leverage the growing trend towards personalized medicine and digital therapy tools to enhance user engagement and treatment efficacy.

KEY MARKET STATISTICS
Base Year [2023] USD 1.21 billion
Estimated Year [2024] USD 1.28 billion
Forecast Year [2030] USD 1.88 billion
CAGR (%) 6.50%

However, the market faces limitations such as stigmatization associated with AUD, high treatment costs, and stringent regulatory frameworks, which can hinder market penetration. Additionally, cultural variations and lack of awareness in developing regions pose challenges to growth. Key areas for innovation include the development of more effective and less addictive medications, AI-driven solutions for early detection and personalized treatment plans, and comprehensive support systems integrating telehealth with traditional therapy. Insights into this market reveal a trend towards holistic approaches that combine pharmacological and behavioral interventions. The nature of the market is dynamic, driven by shifting societal attitudes towards mental health and rapidly evolving technological landscapes. By focusing on integrated care models and leveraging data analytics, businesses can not only enhance treatment outcomes but also expand their market presence, ensuring robust growth in addressing Alcohol Use Disorder effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Alcohol Use Disorder Market

The Alcohol Use Disorder Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of substance abuse cases across the world
    • Government initiatives and schemes to prevent, diagnose, and treat alcohol abuse disorder
    • Proliferation of digital and telehealth strategies for preventing and managing alcohol use
  • Market Restraints
    • Performance limitations and complexities in evaluating efficiency
  • Market Opportunities
    • Research initiatives and advancements to improve the efficacy and efficiency of alcohol use disorder therapeutics and diagnostics
    • Ongoing approvals for devices, drugs, and formulations that help manage alcohol use
  • Market Challenges
    • Complexities in developing alcohol use disorder therapeutics and diagnostics strategies

Porter's Five Forces: A Strategic Tool for Navigating the Alcohol Use Disorder Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Alcohol Use Disorder Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Alcohol Use Disorder Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Alcohol Use Disorder Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Alcohol Use Disorder Market

A detailed market share analysis in the Alcohol Use Disorder Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Alcohol Use Disorder Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Alcohol Use Disorder Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Alcohol Use Disorder Market

A strategic analysis of the Alcohol Use Disorder Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alcohol Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Addex Therapeutics, Adial Pharmaceuticals, Alkermes, Astellas Pharma, Beckley Psytech Limited, BioCorRx, Inc., Bioprojet, Clairvoyant Therapeutics, Corcept Therapeutics Inc., GlaxoSmithKline PLC, Indivior Inc., Kinnov Therapeutics, Kinoxis Therapeutics, Lundbeck, MediciNova, Merck & Co. Inc., Omeros Corporation, Otsuka Pharmaceuticals, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Alcohol Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Behavioral Therapy, Detoxification, Inpatient Rehabilitation, and Medication.
  • Based on Disorder Type, market is studied across Alcohol Abuse, Alcohol Dependence, and High-Functioning Alcoholism.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies and Retail Pharmacies & Drug Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of substance abuse cases across the world
      • 5.1.1.2. Government initiatives and schemes to prevent, diagnose, and treat alcohol abuse disorder
      • 5.1.1.3. Proliferation of digital and telehealth strategies for preventing and managing alcohol use
    • 5.1.2. Restraints
      • 5.1.2.1. Performance limitations and complexities in evaluating efficiency
    • 5.1.3. Opportunities
      • 5.1.3.1. Research initiatives and advancements to improve the efficacy and efficiency of alcohol use disorder therapeutics and diagnostics
      • 5.1.3.2. Ongoing approvals for devices, drugs, and formulations that help manage alcohol use
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in developing alcohol use disorder therapeutics and diagnostics strategies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Type: Rising preference for behavioral therapies to effectively control alcohol use disorder
    • 5.2.2. Distribution Channel: Increasing utilization of over-the-counter medications by retail pharmacies to support recovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Alcohol Use Disorder Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Behavioral Therapy
  • 6.3. Detoxification
  • 6.4. Inpatient Rehabilitation
  • 6.5. Medication

7. Alcohol Use Disorder Market, by Disorder Type

  • 7.1. Introduction
  • 7.2. Alcohol Abuse
  • 7.3. Alcohol Dependence
  • 7.4. High-Functioning Alcoholism

8. Alcohol Use Disorder Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Retail Pharmacies & Drug Stores

9. Americas Alcohol Use Disorder Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Alcohol Use Disorder Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Alcohol Use Disorder Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Researchers Receive USD 3.4 Million Grant to Study Alcohol Use Disorder Among People with Disabilities
    • 12.3.2. Affect Raises USD 16 Million As Addiction-Related Financings Hold Strong
    • 12.3.3. Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addex Therapeutics
  • 2. Adial Pharmaceuticals
  • 3. Alkermes
  • 4. Astellas Pharma
  • 5. Beckley Psytech Limited
  • 6. BioCorRx, Inc.
  • 7. Bioprojet
  • 8. Clairvoyant Therapeutics
  • 9. Corcept Therapeutics Inc.
  • 10. GlaxoSmithKline PLC
  • 11. Indivior Inc.
  • 12. Kinnov Therapeutics
  • 13. Kinoxis Therapeutics
  • 14. Lundbeck
  • 15. MediciNova
  • 16. Merck & Co. Inc.
  • 17. Omeros Corporation
  • 18. Otsuka Pharmaceuticals
  • 19. Sun Pharmaceutical Industries Limited
  • 20. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ALCOHOL USE DISORDER MARKET RESEARCH PROCESS
  • FIGURE 2. ALCOHOL USE DISORDER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALCOHOL USE DISORDER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALCOHOL USE DISORDER MARKET DYNAMICS
  • TABLE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DETOXIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL ABUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL DEPENDENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HIGH-FUNCTIONING ALCOHOLISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023